ClinicalTrials.Veeva

Menu

Clinical Performance of Adhesive Systems Containing HEMA and 10-MDP in Non Carious Cervical Lesions

U

Universidade Federal do Para

Status

Completed

Conditions

Non Carious Cervical Lesion

Treatments

Other: composite resin restoration

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The objective of this randomized, double-blind clinical trial is to evaluate the clinical performance of non-carious cervicals adhesive restorations using three self-etching adhesives containing HEMA and 10-MDP monomers.

Full description

Sixty teeth (n = 20 for each group) will be randomized into 03 groups: Clearfil SE (contains MDP and HEMA), Optibond All-inOne (contains HEMA) and Prime and Bond Universal (contains neither monomer) dispatch). Restorations will be performed by a single operator, and no mechanical retention will be performed under the cavity. After 6, 12 and 24 months, the restorations will be evaluated by two calibrated examiners, using modified USPHS criteria for retention (kappa = 1.00) and adaptation / marginal color (kappa = 0.81), and the results will be analysed by Fisher and Kruskal-Wallis, respectively. An intragroup analysis will be performed using the Cochran test (for retention) and Wilcoxon (for marginal adaptation / staining).

Enrollment

18 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Good oral hygiene
  • Absence of periodontal disease
  • Presence of at least 02 non-carious cervical lesions

Exclusion criteria

  • Presence of non-carious cervical lesion in non-vital teeth
  • Occlusal instability
  • Presence of orthodontic appliance
  • Presence of removable partial dental prosthesis
  • High risk of caries (presence of three or more active caries lesions)
  • Xerostomia
  • Bruxism
  • Patients allergic to base materials monomers
  • Patients who do not accept the project conditions

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

18 participants in 3 patient groups

Clearfil SE
Active Comparator group
Description:
Group containing 10-MDP and HEMA monomers
Treatment:
Other: composite resin restoration
Optibond All-in-One
Active Comparator group
Description:
Group containing HEMA monomer
Treatment:
Other: composite resin restoration
Prime & Bond Universal
Active Comparator group
Description:
Control Group containing other monomers
Treatment:
Other: composite resin restoration

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems